The most recent listing of current clinical trials for gynecological cancers — including cervix, endometrium, ovarian, vulva and vagina — appears below. Should you be interested in learning more about any of these clinical trials, please use our Contact Us form.
Site: Gynecology,
(Includes Cervix, Endometrium,
Ovarian, Vulva and Vagina)
| Protocol ID |
|
Title |
|
RTOG 0417
|
|
Phase II Study of Bevacizumab in Combination with Definitive Radiotherapy and Cisplatin Chemotherapy in Untreated Patients with Locally Advanced Cervical Carcinoma
Keywords: Locally Advanced Cervical Carcinoma |
|
RTOG 0418
|
|
A Phase II Study of Intensity Modulated Radiation Therapy (IMRT) to the Pelvis +/- Chemotherapy for Post-Operative Patients with Either Endometrial or Cervical Carcinoma
Keywords: Post-Operative Patients with Either Endometrial or Cervical Carcinoma |
|
GOG 0219
|
|
A Phase III, Randomized Trial of Weekly Cisplatin and Radiation versus Cisplatin and Tirapazamine and Radiation in Stage IB2, IIA, IIB, IIIB and IVA Cervical Carcinoma Limited to the Pelvis
Keywords: Stage IB2, IIA, IIB, IIIB and IVA Cervical Carcinoma Limited to the Pelvis |
|
GOG 0209
|
|
A Randomized Phase III Trial of Doxorubicin/ Cisplatin/ Paclitaxel and G-CSF versus Carboplatin/ Paclitaxel in Patients with Stage III or IV or Recurrent Endometrial Cancer
Keywords: Stage III or IV or Recurrent Endometrial Cancer |
|
GOG #0227E
|
|
A Phase II Evaluation of Cetuximab (Erbitux ®, C225, NSC #714692) in the treatment of Persistent or Recurrent Squamous or Non-Squamous Cell Carcinoma of the Cervix
Keywords: Persistent or Recurrent Squamous or Non-Squamous Cell Carcinoma of the Cervix |
|
In-House
|
|
The Incidence of Lymphedema in Patients Undergoing Pelvic and/ or Para-aortic Lymph Node Dissection with Laparoscopic or Total Abdominal Hysterectomy
Keywords: Patients Undergoing Pelvic and/ or Para-aortic Lymph Node Dissection with Laparoscopic or Total Abdominal Hysterectomy |